التفاصيل البيبلوغرافية
| العنوان: |
KAT6A mutations in Arboleda-Tham syndrome drive epigenetic regulation of posterior HOXC cluster. |
| المؤلفون: |
Singh, Meghna, Spendlove, Sarah J., Wei, Angela, Bondhus, Leroy M., Nava, Aileen A., de L. Vitorino, Francisca N., Amano, Seth, Lee, Jacob, Echeverria, Gesenia, Gomez, Dianne, Garcia, Benjamin A., Arboleda, Valerie A. |
| المصدر: |
Human Genetics; Dec2023, Vol. 142 Issue 12, p1705-1720, 16p |
| مصطلحات موضوعية: |
EPIGENETICS, REGULATOR genes, POST-translational modification, AUTOMATIC speech recognition, GENETIC mutation, CELLULAR control mechanisms, HOMEOBOX genes |
| مستخلص: |
Arboleda-Tham Syndrome (ARTHS) is a rare genetic disorder caused by heterozygous, de novo mutations in Lysine(K) acetyltransferase 6A (KAT6A). ARTHS is clinically heterogeneous and characterized by several common features, including intellectual disability, developmental and speech delay, and hypotonia, and affects multiple organ systems. KAT6A is the enzymatic core of a histone–acetylation protein complex; however, the direct histone targets and gene regulatory effects remain unknown. In this study, we use ARTHS patient (n = 8) and control (n = 14) dermal fibroblasts and perform comprehensive profiling of the epigenome and transcriptome caused by KAT6A mutations. We identified differential chromatin accessibility within the promoter or gene body of 23% (14/60) of genes that were differentially expressed between ARTHS and controls. Within fibroblasts, we show a distinct set of genes from the posterior HOXC gene cluster (HOXC10, HOXC11, HOXC-AS3, HOXC-AS2, and HOTAIR) that are overexpressed in ARTHS and are transcription factors critical for early development body segment patterning. The genomic loci harboring HOXC genes are epigenetically regulated with increased chromatin accessibility, high levels of H3K23ac, and increased gene–body DNA methylation compared to controls, all of which are consistent with transcriptomic overexpression. Finally, we used unbiased proteomic mass spectrometry and identified two new histone post-translational modifications (PTMs) that are disrupted in ARTHS: H2A and H3K56 acetylation. Our multi-omics assays have identified novel histone and gene regulatory roles of KAT6A in a large group of ARTHS patients harboring diverse pathogenic mutations. This work provides insight into the role of KAT6A on the epigenomic regulation in somatic cell types. [ABSTRACT FROM AUTHOR] |
|
Copyright of Human Genetics is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
